UnitedHealth (UNH) Stock Forecast & Price Target

Compare

69 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

UNH Analyst Ratings

Strong Buy

17 Buy

3 Hold

1 Sell

Based on 21 analysts giving stock ratings to

UnitedHealth

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

UNH Stock 12 Month Forecast

Average Price Target

€338.08

▲(18.88% Upside)

Based on 21 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is €338.08 with a high forecast of €377.60 and a low forecast of €223.13. The average price target represents a 18.88% change from the last price of €284.40.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"207":"€207","297":"€297","387":"€387","477":"€477","567":"€567"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":377.6039652,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€377.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":338.0842774785,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€338.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":223.1296158,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€223.13</span>\n  </div></div>","useHTML":true}}],"tickPositions":[207,297,387,477,567],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,295.95,302.2310742461538,308.5121484923077,314.7932227384615,321.0742969846154,327.3553712307692,333.6364454769231,339.9175197230769,346.1985939692308,352.4796682153846,358.7607424615385,365.0418167076923,371.3228909538461,{"y":377.6039652,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,295.95,299.19109826757693,302.4321965351538,305.67329480273077,308.91439307030765,312.1554913378846,315.39658960546154,318.63768787303843,321.8787861406154,325.1198844081923,328.3609826757692,331.60208094334615,334.84317921092304,{"y":338.0842774785,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,295.95,290.3484319846154,284.7468639692308,279.14529595384613,273.54372793846153,267.94215992307693,262.3405919076923,256.73902389230767,251.13745587692307,245.53588786153847,239.93431984615384,234.33275183076924,228.7311838153846,{"y":223.1296158,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":513.949,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":566.616,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":476.949,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":514.734,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":446.977,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":480.671,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":356.321,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":261.727,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 72,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":274.049,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 65,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":208.754,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":263.962,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.45,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 57,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":295.95,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€377.60

Average Price Target€338.08

Lowest Price Target€223.13

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stephen Baxter

Wells Fargo

€343.73

Buy

20.86%

Upside

Reiterated

11/12/25

Analysts' Top Healthcare Picks: Shoulder Innovations, Inc. (SI), Zoetis (ZTS)

Ann Hynes

Mizuho Securities

―

Buy

―

Reiterated

11/06/25

David S Macdonald

Truist Financial

€352.33

Buy

23.88%

Upside

Reiterated

11/03/25

Truist Financial Reaffirms Their Buy Rating on UnitedHealth (UNH)

Andrew Mok CFA

Barclays

€331.7

Buy

16.63%

Upside

Reiterated

11/03/25

Barclays Sticks to Their Buy Rating for UnitedHealth (UNH)

Lance Wilkes

Bernstein

€372.09→€378.1

Buy

32.95%

Upside

Reiterated

10/30/25

Positive Outlook for UnitedHealth: Strong Earnings Recovery and Strategic Positioning in Value-Based Care

Ryan Langston

TD Cowen

€287.88→€290.45

Hold

2.13%

Upside

Reiterated

10/30/25

UnitedHealth: Navigating 2026 Challenges with Strategic Growth Plans for a Promising 2027

Erin Wright

Morgan Stanley

€339.44→€353.18

Buy

24.19%

Upside

Reiterated

10/29/25

Optimistic Outlook for UnitedHealth: Buy Rating Based on Recovery and Growth Potential

Michael Wiederhorn

Oppenheimer

€279.28→€356.62

Buy

25.39%

Upside

Reiterated

10/29/25

UnitedHealth price target raised to $415 from $325 at OppenheimerUnitedHealth price target raised to $415 from $325 at Oppenheimer

A.J. Rice

UBS

€324.83→€369.51

Buy

29.93%

Upside

Reiterated

10/29/25

UnitedHealth price target raised to $430 from $378 at UBSUnitedHealth price target raised to $430 from $378 at UBS

George Hill

Deutsche Bank

€236.32→€286.16

Hold

0.62%

Upside

Downgraded

10/29/25

UnitedHealth downgraded to Hold from Buy at Deutsche BankUnitedHealth downgraded to Hold from Buy at Deutsche Bank

Kevin Fischbeck

Bank of America Securities

€335.14→€352.33

Hold

23.88%

Upside

Reiterated

10/29/25

Analysts Offer Insights on Healthcare Companies: Alkermes (NASDAQ: ALKS), Medtronic (NYSE: MDT) and UnitedHealth (NYSE: UNH)

Jessica Tassan

Piper Sandler

€363.5→€358.34

Buy

26.00%

Upside

Reiterated

10/29/25

UnitedHealth (UNH) Receives a Buy from Piper Sandler

David Windley

Jefferies

€351.47→€359.2

Buy

26.30%

Upside

Reiterated

10/28/25

UnitedHealth Poised for Growth: Buy Rating Affirmed on Strong EPS Outlook and Effective Cost Management

Scott Fidel

Goldman Sachs

€311.51→€348.89

Buy

22.68%

Upside

Reiterated

10/28/25

UnitedHealth's Strong Financial Performance and Strategic Adjustments Justify Buy Rating

Ben Hendrix

RBC Capital

€245.77→€350.61

Buy

23.28%

Upside

Reiterated

10/28/25

Analysts Offer Insights on Healthcare Companies: Gyre Therapeutics (NASDAQ: GYRE), Regeneron (NASDAQ: REGN) and UnitedHealth (NYSE: UNH)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stephen Baxter

Wells Fargo

€343.73

Buy

20.86%

Upside

Reiterated

11/12/25

Analysts' Top Healthcare Picks: Shoulder Innovations, Inc. (SI), Zoetis (ZTS)

Ann Hynes

Mizuho Securities

―

Buy

―

Reiterated

11/06/25

David S Macdonald

Truist Financial

€352.33

Buy

23.88%

Upside

Reiterated

11/03/25

Truist Financial Reaffirms Their Buy Rating on UnitedHealth (UNH)

Andrew Mok CFA

Barclays

€331.7

Buy

16.63%

Upside

Reiterated

11/03/25

Barclays Sticks to Their Buy Rating for UnitedHealth (UNH)

Lance Wilkes

Bernstein

€372.09→€378.1

Buy

32.95%

Upside

Reiterated

10/30/25

Positive Outlook for UnitedHealth: Strong Earnings Recovery and Strategic Positioning in Value-Based Care

Ryan Langston

TD Cowen

€287.88→€290.45

Hold

2.13%

Upside

Reiterated

10/30/25

UnitedHealth: Navigating 2026 Challenges with Strategic Growth Plans for a Promising 2027

Erin Wright

Morgan Stanley

€339.44→€353.18

Buy

24.19%

Upside

Reiterated

10/29/25

Optimistic Outlook for UnitedHealth: Buy Rating Based on Recovery and Growth Potential

Michael Wiederhorn

Oppenheimer

€279.28→€356.62

Buy

25.39%

Upside

Reiterated

10/29/25

UnitedHealth price target raised to $415 from $325 at OppenheimerUnitedHealth price target raised to $415 from $325 at Oppenheimer

A.J. Rice

UBS

€324.83→€369.51

Buy

29.93%

Upside

Reiterated

10/29/25

UnitedHealth price target raised to $430 from $378 at UBSUnitedHealth price target raised to $430 from $378 at UBS

George Hill

Deutsche Bank

€236.32→€286.16

Hold

0.62%

Upside

Downgraded

10/29/25

UnitedHealth downgraded to Hold from Buy at Deutsche BankUnitedHealth downgraded to Hold from Buy at Deutsche Bank

Kevin Fischbeck

Bank of America Securities

€335.14→€352.33

Hold

23.88%

Upside

Reiterated

10/29/25

Analysts Offer Insights on Healthcare Companies: Alkermes (NASDAQ: ALKS), Medtronic (NYSE: MDT) and UnitedHealth (NYSE: UNH)

Jessica Tassan

Piper Sandler

€363.5→€358.34

Buy

26.00%

Upside

Reiterated

10/29/25

UnitedHealth (UNH) Receives a Buy from Piper Sandler

David Windley

Jefferies

€351.47→€359.2

Buy

26.30%

Upside

Reiterated

10/28/25

UnitedHealth Poised for Growth: Buy Rating Affirmed on Strong EPS Outlook and Effective Cost Management

Scott Fidel

Goldman Sachs

€311.51→€348.89

Buy

22.68%

Upside

Reiterated

10/28/25

UnitedHealth's Strong Financial Performance and Strategic Adjustments Justify Buy Rating

Ben Hendrix

RBC Capital

€245.77→€350.61

Buy

23.28%

Upside

Reiterated

10/28/25

Analysts Offer Insights on Healthcare Companies: Gyre Therapeutics (NASDAQ: GYRE), Regeneron (NASDAQ: REGN) and UnitedHealth (NYSE: UNH)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UnitedHealth

1 Month

xxx

Success Rate

25/35 ratings generated profit

Average Return

+2.18%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +2.18% per trade.

3 Months

xxx

Success Rate

29/44 ratings generated profit

Average Return

+5.42%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 65.91% of your transactions generating a profit, with an average return of +5.42% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

35/43 ratings generated profit

Average Return

+20.85%

reiterated a buy rating last month

Copying Scott Fidel's trades and holding each position for 1 Year would result in 81.40% of your transactions generating a profit, with an average return of +20.85% per trade.

2 Years

xxx

Success Rate

38/44 ratings generated profit

Average Return

+43.08%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 86.36% of your transactions generating a profit, with an average return of +43.08% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNH Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, UNH has received 50 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. UNH average Analyst price target in the past 3 months is 338.08.

Each month's total comprises the sum of three months' worth of ratings.

UNH Financial Forecast

UNH Earnings Forecast

Next quarter’s earnings estimate for UNH is €1.81 with a range of €1.62 to €2.16. The previous quarter’s EPS was €2.51. UNH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.

UNH Sales Forecast

Next quarter’s sales forecast for UNH is €97.42B with a range of €93.80B to €99.32B. The previous quarter’s sales results were €97.24B. UNH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year UNH has Performed in-line its overall industry.

UNH Stock Forecast FAQ

What is DE:UNH’s average 12-month price target, according to analysts?

Based on analyst ratings, UnitedHealth’s 12-month average price target is 338.08.

What is DE:UNH’s upside potential, based on the analysts’ average price target?

UnitedHealth has 18.88% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is UnitedHealth a Buy, Sell or Hold?

UnitedHealth has a consensus rating of Strong Buy, which is based on 17 buy ratings, 3 hold ratings and 1 sell ratings.

What is UnitedHealth’s share price target?

The average share price target for UnitedHealth is 338.08. This is based on 21 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €377.60 ,and the lowest forecast is €223.13. The average share price target represents 18.88% Increase from the current price of €284.4.

What do analysts say about UnitedHealth?

UnitedHealth’s analyst rating consensus is a Strong Buy. This is based on the ratings of 21 Wall Streets Analysts.

How can I buy shares of UnitedHealth?

To buy shares of DE:UNH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

UnitedHealth (UNH) Stock Forecast & Price Target

UNH Analyst Ratings

UNH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering UnitedHealth

UNH Analyst Recommendation Trends

UNH Financial Forecast

UNH Earnings Forecast

UNH Sales Forecast

UNH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts